C8383
Chloral hydrate
Synonym(s):
Trichloroacetaldehyde hydrate
Sign Into View Organizational & Contract Pricing
All Photos(4)
About This Item
Linear Formula:
Cl3CCH(OH)2
CAS Number:
Molecular Weight:
165.40
Beilstein:
1698497
EC Number:
MDL number:
UNSPSC Code:
51111800
PubChem Substance ID:
NACRES:
NA.77
Recommended Products
Assay
≥98% (titration)
Quality Level
form
powder
drug control
USDEA Schedule IV
mp
57 °C (lit.)
SMILES string
OC(O)C(Cl)(Cl)Cl
InChI
1S/C2H3Cl3O2/c3-2(4,5)1(6)7/h1,6-7H
InChI key
RNFNDJAIBTYOQL-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Biochem/physiol Actions
Chloral hydrate is a sedative/hypnotic.
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2
Storage Class Code
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Jennifer Ngolab et al.
Acta neuropathologica communications, 8(1), 123-123 (2020-08-06)
An amendment to this paper has been published and can be accessed via the original article.
Xin Fang et al.
Journal of neurochemistry, 150(4), 441-452 (2019-03-10)
While glucagon-like peptide-1 (GLP-1) was reported to have a positive impact on Parkinson disease, it is extremely short half-life greatly hindered its clinical use. In this study, the mouse strain MG1363-pMG36e-GLP-1 was engineered to continuously express GLP-1 to treat Parkinson
Megan M Monsanto et al.
Nature communications, 11(1), 3955-3955 (2020-08-10)
Cellular therapy to treat heart failure is an ongoing focus of intense research, but progress toward structural and functional recovery remains modest. Engineered augmentation of established cellular effectors overcomes impediments to enhance reparative activity. Such 'next generation' implementation includes delivery
Ya-Chen Ko et al.
Journal of anatomy, 214(1), 183-195 (2009-01-27)
CD200 is a highly glycosylated cell surface protein containing two immunoglobulin superfamily domains in the extracellular region and performs immunosuppressive activities. It is widely distributed in various tissues including the vascular endothelium. We report here the distribution of CD200 in
Stephanie K West et al.
The British journal of ophthalmology, 97(11), 1437-1442 (2013-09-21)
To report the largest study on the safety and effectiveness of sedation in paediatric ophthalmology in a nurse-led outpatient sedation unit. Retrospective cohort study reviewing all children who underwent sedation from January 2006 to December 2010. Patients were sedated with
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service